16904-30-6

Basic information

• Product Name: USAF LA-10
• Synonyms: USAF LA-10
• CAS NO: 16904-30-6
• Molecular Formula: C8H14Cl2N2
• Molecular Weight: 209.11616
• Mol File: 16904-30-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 281.4°C at 760 mmHg
• Flash Point: 143.7°C
• Appearance: /
• Vapor Pressure: 0.00358mmHg at 25°C
• CAS DataBase Reference: USAF LA-10(CAS DataBase Reference)
• NIST Chemistry Reference: USAF LA-10(16904-30-6)
• EPA Substance Registry System: USAF LA-10(16904-30-6)

Safety Data

• Hazardous Substances Data: 16904-30-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H12N2.2ClH/c9-10-7-6-8-4-2-1-3-5-8;;/h1-5,10H,6-7,9H2;2*1H

Upstream product

• 1251463-81-6 C₁₆H₂₄N₂O₂ 
• 103-63-9 1-phenyl-2-bromoethane 

Downstream Products

• 32500-75-7 3-methyl-1-(2-phenethyl)pyrazole 
• 1431660-74-0 C₁₅H₁₁Cl₂NO 
• 56366-15-5 5-methyl-3-phenyl-1H-indole 
• 1431660-75-1 5-ethyl-3-phenyl-1H-indole 
• 1431660-76-2 3,5-diphenyl-1H-indole 
• 1431660-77-3 C₁₇H₁₇N 
• 56366-17-7 5,7-dimethyl-3-phenyl-1H-indole 
• 1431660-78-4 C₁₈H₁₇N 
• 56366-26-8 5-methoxy-3-phenyl-1Η-indole 
• 1431660-63-7 C₁₆H₁₅NO₂ 
• 1431660-64-8 C₁₅H₁₂INO 
• 1431660-65-9 C₁₅H₁₂INO 
• 1431660-66-0 C₁₅H₁₂BrNO 
• 1431660-67-1 C₁₅H₁₂BrNO 

Relevant articles and documents

PYRAZOLOPYRAZINES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (IIa) or (IIb), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph,codrug, cocrystal,prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.

ANTIVIRAL PYRIMIDINES

Disclosed herein are novel compounds comprising substituted pyrimidines, pyrazolopyrimtdines, and imidazolopyrimidines, the syntheses thereof, and compositions thereof, including pharmaceutical compositions, comprising the novel pyrimidines, pyrazolopyrimtdines, imidazolpyrimidines and related compounds. Such compounds function to inhibit entry of viruses of the Flaviviridae family, including Hepatitis C virus (HCV), into cells that are susceptible to virus infection. These compounds are useful for the treatment, therapy and/or prophylaxis of viral diseases and infection, including HCV infection.